Figure1. Comparison of Treatments in Tumor-Bearing Mice (IMAGE)

Kanazawa University

Figure1. Comparison of Treatments in Tumor-Bearing Mice

Caption

Combination therapy with 211At-labeled RGD peptide and immune checkpoint inhibitor (anti-CTLA-4 antibody) resulted in greater tumor growth suppression and improved survival compared to monotherapies in tumor-bearing mice.  (Figure modified from Original by the author.)

Credit

🄫Echigo H et al.,Eur. J. Nucl. Med. Mol. Imaging, https://doi.org/10.1007/s00259-025-07498-3. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.